These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 34479496)

  • 1. Case report: Osteomalacia due to bisphosphonate treatment in a patient on hemodialysis.
    Hatano M; Kitajima I; Yamamoto S; Nakamura M; Isawa K; Hirota Y; Hoshino J; Sawa N; Ubara Y
    BMC Nephrol; 2021 Sep; 22(1):298. PubMed ID: 34479496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteomalacia in a patient with Paget's bone disease treated with long-term etidronate.
    Hoppé E; Masson C; Laffitte A; Chappard D; Audran M
    Morphologie; 2012 Aug; 96(313):40-3. PubMed ID: 23022200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diaphyseal femoral fracture due to severe vitamin D
    Hatano M; Kitajima I; Isawa K; Hirota Y; Suwabe T; Hoshino J; Sawa N; Nakamura M; Yamamoto S; Ubara Y
    Arch Osteoporos; 2020 Nov; 15(1):179. PubMed ID: 33180218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical osteomalacia after 2 year etidronate intermittent cyclic administration in osteoporosis.
    Thomas T; Lafage MH; Alexandre C
    J Rheumatol; 1995 Nov; 22(11):2183-5. PubMed ID: 8596168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteomalacia in a hemodialysis patient receiving an active vitamin D sterol.
    Hernandez JD; Wesseling K; Boechat MI; Gales B; Salusky IB
    Nat Clin Pract Nephrol; 2007 Apr; 3(4):227-32. PubMed ID: 17389892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histopathology of renal osteodystrophy with particular reference to the effects of 1alpha-hydroxyvitamin D3 in patients treated by long-term haemodialysis.
    Ellis HA; Pierides AM; Feest TG; Ward MK; Kerr DN
    Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():31s-38s. PubMed ID: 606422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone histomorphometric changes after cyclic therapy with phosphate and etidronate disodium in women with postmenopausal osteoporosis.
    Ott SM; Woodson GC; Huffer WE; Miller PD; Watts NB
    J Clin Endocrinol Metab; 1994 Apr; 78(4):968-72. PubMed ID: 8157728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple fractures in a woman receiving 24 years of etidronate treatment for Paget's disease.
    Labinson P; Taxel P
    Conn Med; 2007 May; 71(5):269-73. PubMed ID: 17526382
    [No Abstract]   [Full Text] [Related]  

  • 9. Renal osteodystrophy in dialysis patients: diagnosis and treatment.
    Fournier A; Oprisiu R; Hottelart C; Yverneau PH; Ghazali A; Atik A; Hedri H; Said S; Sechet A; Rasolombololona M; Abighanem O; Sarraj A; El Esper N; Moriniere P; Boudailliez B; Westeel PF; Achard JM; Pruna A
    Artif Organs; 1998 Jul; 22(7):530-57. PubMed ID: 9684690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A four-year randomized controlled trial of hormone replacement and bisphosphonate, alone or in combination, in women with postmenopausal osteoporosis.
    Wimalawansa SJ
    Am J Med; 1998 Mar; 104(3):219-26. PubMed ID: 9552083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteomalacia in Paget's disease treated with short term, high dose sodium etidronate.
    Gibbs CJ; Aaron JE; Peacock M
    Br Med J (Clin Res Ed); 1986 May; 292(6530):1227-9. PubMed ID: 3085789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of calciferol and its metabolites on patients with chronic renal failure. II. Calcitriol, 1 alpha-hydroxyvitamin D3, and 24,25-dihydroxyvitamin D3.
    Voigts AL; Felsenfeld AJ; Llach F
    Arch Intern Med; 1983 Jun; 143(6):1205-11. PubMed ID: 6344827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Denosumab improves clinical manifestations of hypophosphatemic osteomalacia by adefovir-induced Fanconi syndrome: a case report.
    Kunii T; Iijima T; Jojima T; Shimizu M; Kase M; Sakurai S; Kogai T; Usui I; Aso Y
    J Med Case Rep; 2019 Apr; 13(1):99. PubMed ID: 31003599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of continuous alendronate, cyclical alendronate and cyclical etidronate with calcitriol in the treatment of postmenopausal vertebral osteoporosis: a randomized controlled trial.
    Sahota O; Fowler I; Blackwell PJ; Lawson N; Cawte SA; San P; Masud T; Hosking DJ
    Osteoporos Int; 2000; 11(11):959-66. PubMed ID: 11193249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of alendronate versus etidronate for the treatment of Paget's disease of bone.
    Siris E; Weinstein RS; Altman R; Conte JM; Favus M; Lombardi A; Lyles K; McIlwain H; Murphy WA; Reda C; Rude R; Seton M; Tiegs R; Thompson D; Tucci JR; Yates AJ; Zimering M
    J Clin Endocrinol Metab; 1996 Mar; 81(3):961-7. PubMed ID: 8772558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe osteomalacia caused by short bowel syndrome in a patient on long-term hemodialysis after parathyroidectomy.
    Yamauchi J; Ubara Y; Suwabe T; Yamanouchi M; Hayami N; Sumida K; Hiramatsu E; Hasegawa E; Hoshino J; Sawa N; Takemoto F; Marui Y; Nakamura M; Tomikawa S; Takaichi K
    J Bone Miner Metab; 2011 Mar; 29(2):245-50. PubMed ID: 21069547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. History of etidronate.
    Watts NB; Chesnut CH; Genant HK; Harris ST; Jackson RD; Licata AA; Miller PD; Mysiw WJ; Richmond B; Valent D
    Bone; 2020 May; 134():115222. PubMed ID: 31911206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of cyclical etidronate combined with calcitriol versus cyclical etidronate alone on spine and femoral neck bone mineral density in postmenopausal osteoporotic women.
    Masud T; Mulcahy B; Thompson AV; Donnelly S; Keen RW; Doyle DV; Spector TD
    Ann Rheum Dis; 1998 Jun; 57(6):346-9. PubMed ID: 9771208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclical etidronate in the treatment of postmenopausal osteoporosis: efficacy and safety after seven years of treatment.
    Miller PD; Watts NB; Licata AA; Harris ST; Genant HK; Wasnich RD; Ross PD; Jackson RD; Hoseyni MS; Schoenfeld SL; Valent DJ; Chesnut CH
    Am J Med; 1997 Dec; 103(6):468-76. PubMed ID: 9428829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.